Brief: Bayer Signs Licensing Agreement With RAGT
15/07/2026 08:33
BRIEF-Bayer Signs Licensing Agreement With RAGT July 15 (Reuters) - BAYER AG BAYGn.DE:
BAYER SIGNS LICENSING AGREEMENT WITH RAGT AND BEGINS BROAD HYBRID WHEAT COMMERCIALIZATION BY EARLY 2030S
SALES EXPECTED TO REACH 1 BILLION EUROS ANNUALLY BY MID-2040S
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women